Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

rapacuronium

Known as: rapacuronium [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Preclinical Safety Pharmacology (PSP) attempts to anticipate adverse drug reactions (ADRs) during early phases of drug discovery… Expand
Review
2006
Review
2006
Lethal hyperkalemic response to succinylcholine continues to be reported, but the molecular mechanisms for the hyperkalemia have… Expand
Highly Cited
2003
Highly Cited
2003
Background A safe and effective ultra-short-acting nondepolarizing neuromuscular blocking agent is required to block nicotinic… Expand
Review
2002
Review
2002
We conducted this study to determine the risk factors for the development of bronchospasm after the administration of… Expand
2001
2001
IN December 2000, subscribers to the Paediatric Anaesthesia Conference discussion group were invited to post their experiences… Expand
2001
2001
  • M. Naguib
  • Anesthesiology
  • 2001
  • Corpus ID: 1931763
RAPACURONIUM (16-N-allyl, 17-β-propionate analog of vecuronium) is a new rapid-onset, short-acting, nondepolarizing steroidal… Expand
2000
2000
The purpose of this nine-centre study in 602 patients was to show that the frequency of acceptable intubating conditions after… Expand
Highly Cited
1999
Highly Cited
1999
We have assessed intubating conditions provided by rapacuronium (Org 9487) and succinylcholine after rapid sequence induction of… Expand
  • table 1
  • table 2
1999
1999
BACKGROUND Rapacuronium is a rapid-onset, short-acting neuromuscular relaxant. This multiple-center study determined… Expand
1999
1999
UNLABELLED Rapacuronium (Org 9487) is a rapid-onset and short- to intermediate-acting muscle relaxant. Its 3-desacetyl metabolite… Expand